Omega Diagnostics Share Discussion Threads

[rivaldo] 06/4/2016 14:42

The year end trading update has been 14th and 15th April the last two years, so only a week to go.

Finncap and Edison both go for 1.3p EPS, with 1.4p EPS for this year. With 0.6p adjusted EPS in H1 the forecasts look pretty reasonable. And H2 currency movements should be to ODX's benefit.

Plus any decent progress re CD4 and allergy development is in the price for free.

[rivaldo] 16/3/2016 08:39

Bit of an uptrend developing into the year end trading update in mid-April. Not long now.

[longshanks] 04/3/2016 00:16

Wonder if our directors are currently buying; closed period is approaching so it could be their last opportunity before issuing results.

[barrywhit] 08/2/2016 09:28

Very true rivaldo, Sneller had 4.04% in June 2015 so he has added 1% in the last 6months...he must be very confident...

[p1nkfish] 08/2/2016 09:28

he was buying pim about 12p if i remember correctly. look now.

[p1nkfish] 08/2/2016 09:27

when his holding becomes notifiable stuff normally happens afterwards. look at crx (but took a while to play out for him) and pim.

[rivaldo] 08/2/2016 08:50

Indeed - he's bought almost 1.5m shares since his last disclosure in June and now has almost 5.5m.

As a Fund Manager at Baillie Gifford he hopefully knows his stuff, particularly as this is a personally held holding.

[p1nkfish] 08/2/2016 08:49

something is brewing.
good to see RS adding even if a smaller addition.

i hold crx he was adding to last autum and did hold pim he is in also.

crx and pim both have good dynamics.
odx has some of the same hallmarks.
give it 12 - 18 months to show through.

[barrywhit] 08/2/2016 08:26

Richard Sneller still adding to his holding now over 5%,,,,

[rivaldo] 08/2/2016 07:30

Good to see ODX advertising for new positions - "to expand and strengthen our team in the following areas and are looking for talented individuals to help us achieve our ambitious growth targets"

[barrywhit] 07/2/2016 16:08

Leeds,

We should also get an update on the Automated Allergy platform, can't be far off the 40 allergens required and then CE approval, so lots to look forward too..

[leedslad001] 07/2/2016 12:19

Should be an update on CD4 soon!

[rivaldo] 05/2/2016 12:43

Moving nicely upwards now.

[looby loo] 01/2/2016 22:36

Jeffy & Loobrey Loo? No, I don't think that would work Arthur .... :-)

[arthur_lame_stocks] 01/2/2016 22:19

Any relative Looby?

[rivaldo] 13/1/2016 09:50

Bargain time here imo.

Forecasts are 1.3p EPS for the year ending soon and 1.4p EPS next year.

Meanwhile CD4 and the automated allergy products are in the price for free.

[leedslad001] 01/1/2016 18:33

Happy new year all lets hope we all get a bit richer with ODX

[rivaldo] 29/12/2015 09:42

Good interview with the new COO here - reads well:



Extracts:

"Colin King says growth prospects strong for Omega Diagnostics
1 December 2015 6.00am.

Scottish medical testing firm Omega Diagnostics has revealed new plans to drive long-term growth.


The operations of the Alva-based firm have been under review since the appointment of Dundee-based Colin King as chief operating officer in August.

Mr King told The Courier he had been pleased by what he had found as much of the operational foundations were already in place.

But he was convinced there was still strong growth available to the business in markets such as China and America, particularly for its gut-health products.

“Why did I go to Omega from a successful business?” Mr King said.

“Well I didn’t join Omega to manage a £12 million to £15m business; I joined because I believe it has real growth potential and is at the bottom of a growth curve.”"

"Mr Evans said the firm’s automated allergy products were approaching the point where it would become earnings enhancing and progress had been made towards resolving the issues with its flagship CD4 HIV indicating blood test."

[genie] 24/12/2015 11:20

Happy Christmas Barry and to all fellow ODX'ers.

[barrywhit] 24/12/2015 10:27

Merry Christmas All..............Barry

[rivaldo] 08/12/2015 11:32

With 1.3p EPS for the year ending in March, and 1.4p EPS next year, ODX still looks good value to me, particularly with £1.6m in the bank and Allersys and CD4 in for free.

[weatherman] 07/12/2015 13:26

I accepted a hamper from Barclays...perhaps i should have asked for more...

[hyperboreus] 04/12/2015 16:54

L&G, otherwise known 'as a group of people happy to sell' reducing their various holdings here were responsible for the other trade on 2 December:-)



Perhaps a little bit pedantic here rivaldo but institutional shareholders with 3+% totals 57.33% after L&G reducing as no change overall taking into account 2 December trades.